326 related articles for article (PubMed ID: 23727003)
1. Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.
Chu H; Das SC; Fuchs JF; Suresh M; Weaver SC; Stinchcomb DT; Partidos CD; Osorio JE
Vaccine; 2013 Jul; 31(33):3353-60. PubMed ID: 23727003
[TBL] [Abstract][Full Text] [Related]
2. Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine.
Partidos CD; Paykel J; Weger J; Borland EM; Powers AM; Seymour R; Weaver SC; Stinchcomb DT; Osorio JE
Vaccine; 2012 Jun; 30(31):4638-43. PubMed ID: 22583812
[TBL] [Abstract][Full Text] [Related]
3. Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.
Hallengärd D; Kakoulidou M; Lulla A; Kümmerer BM; Johansson DX; Mutso M; Lulla V; Fazakerley JK; Roques P; Le Grand R; Merits A; Liljeström P
J Virol; 2014 Mar; 88(5):2858-66. PubMed ID: 24371047
[TBL] [Abstract][Full Text] [Related]
4. Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling.
Partidos CD; Weger J; Brewoo J; Seymour R; Borland EM; Ledermann JP; Powers AM; Weaver SC; Stinchcomb DT; Osorio JE
Vaccine; 2011 Apr; 29(16):3067-73. PubMed ID: 21300099
[TBL] [Abstract][Full Text] [Related]
5. A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.
García-Arriaza J; Cepeda V; Hallengärd D; Sorzano CÓ; Kümmerer BM; Liljeström P; Esteban M
J Virol; 2014 Mar; 88(6):3527-47. PubMed ID: 24403588
[TBL] [Abstract][Full Text] [Related]
6. A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.
Brandler S; Ruffié C; Combredet C; Brault JB; Najburg V; Prevost MC; Habel A; Tauber E; Desprès P; Tangy F
Vaccine; 2013 Aug; 31(36):3718-25. PubMed ID: 23742993
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model.
Campos RK; Preciado-Llanes L; Azar SR; Kim YC; Brandon O; López-Camacho C; Reyes-Sandoval A; Rossi SL
Front Immunol; 2020; 11():591885. PubMed ID: 33224148
[TBL] [Abstract][Full Text] [Related]
8. Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose.
Roy CJ; Adams AP; Wang E; Plante K; Gorchakov R; Seymour RL; Vinet-Oliphant H; Weaver SC
J Infect Dis; 2014 Jun; 209(12):1891-9. PubMed ID: 24403555
[TBL] [Abstract][Full Text] [Related]
9. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.
Fumagalli MJ; de Souza WM; de Castro-Jorge LA; de Carvalho RVH; Castro ÍA; de Almeida LGN; Consonni SR; Zamboni DS; Figueiredo LTM
J Virol; 2021 Nov; 95(23):e0112221. PubMed ID: 34549980
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice.
Tretyakova I; Hearn J; Wang E; Weaver S; Pushko P
J Infect Dis; 2014 Jun; 209(12):1882-90. PubMed ID: 24585894
[TBL] [Abstract][Full Text] [Related]
11. Liposomal Delivery of the RNA Genome of a Live-Attenuated Chikungunya Virus Vaccine Candidate Provides Local, but Not Systemic Protection After One Dose.
Abeyratne E; Tharmarajah K; Freitas JR; Mostafavi H; Mahalingam S; Zaid A; Zaman M; Taylor A
Front Immunol; 2020; 11():304. PubMed ID: 32194557
[TBL] [Abstract][Full Text] [Related]
12. Chikungunya Virus Evades Antiviral CD8
Davenport BJ; Bullock C; McCarthy MK; Hawman DW; Murphy KM; Kedl RM; Diamond MS; Morrison TE
J Virol; 2020 Apr; 94(9):. PubMed ID: 32102875
[TBL] [Abstract][Full Text] [Related]
13. A novel MVA vectored Chikungunya virus vaccine elicits protective immunity in mice.
Weger-Lucarelli J; Chu H; Aliota MT; Partidos CD; Osorio JE
PLoS Negl Trop Dis; 2014 Jul; 8(7):e2970. PubMed ID: 25058320
[TBL] [Abstract][Full Text] [Related]
14. Chikungunya Virus Strains Show Lineage-Specific Variations in Virulence and Cross-Protective Ability in Murine and Nonhuman Primate Models.
Langsjoen RM; Haller SL; Roy CJ; Vinet-Oliphant H; Bergren NA; Erasmus JH; Livengood JA; Powell TD; Weaver SC; Rossi SL
mBio; 2018 Mar; 9(2):. PubMed ID: 29511072
[TBL] [Abstract][Full Text] [Related]
15. Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus.
Roques P; Ljungberg K; Kümmerer BM; Gosse L; Dereuddre-Bosquet N; Tchitchek N; Hallengärd D; García-Arriaza J; Meinke A; Esteban M; Merits A; Le Grand R; Liljeström P
JCI Insight; 2017 Mar; 2(6):e83527. PubMed ID: 28352649
[TBL] [Abstract][Full Text] [Related]
16. Effects of Chikungunya virus immunity on Mayaro virus disease and epidemic potential.
Webb EM; Azar SR; Haller SL; Langsjoen RM; Cuthbert CE; Ramjag AT; Luo H; Plante K; Wang T; Simmons G; Carrington CVF; Weaver SC; Rossi SL; Auguste AJ
Sci Rep; 2019 Dec; 9(1):20399. PubMed ID: 31892710
[TBL] [Abstract][Full Text] [Related]
17. Effective chikungunya virus-like particle vaccine produced in insect cells.
Metz SW; Gardner J; Geertsema C; Le TT; Goh L; Vlak JM; Suhrbier A; Pijlman GP
PLoS Negl Trop Dis; 2013; 7(3):e2124. PubMed ID: 23516657
[TBL] [Abstract][Full Text] [Related]
18. A chikungunya fever vaccine utilizing an insect-specific virus platform.
Erasmus JH; Auguste AJ; Kaelber JT; Luo H; Rossi SL; Fenton K; Leal G; Kim DY; Chiu W; Wang T; Frolov I; Nasar F; Weaver SC
Nat Med; 2017 Feb; 23(2):192-199. PubMed ID: 27991917
[TBL] [Abstract][Full Text] [Related]
19. Optimized production and immunogenicity of an insect virus-based chikungunya virus candidate vaccine in cell culture and animal models.
Adam A; Luo H; Osman SR; Wang B; Roundy CM; Auguste AJ; Plante KS; Peng BH; Thangamani S; Frolova EI; Frolov I; Weaver SC; Wang T
Emerg Microbes Infect; 2021 Dec; 10(1):305-316. PubMed ID: 33539255
[TBL] [Abstract][Full Text] [Related]
20. Chikungunya Virus Vaccine Candidates with Decreased Mutational Robustness Are Attenuated
Carrau L; Rezelj VV; Noval MG; Levi LI; Megrian D; Blanc H; Weger-Lucarelli J; Moratorio G; Stapleford KA; Vignuzzi M
J Virol; 2019 Sep; 93(18):. PubMed ID: 31270226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]